Welcome to our dedicated page for DNA X SEC filings (Ticker: SONM), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for Sonim Technologies, Inc. (NASDAQ: SONM) provides direct access to the company’s official regulatory disclosures, along with AI-powered tools to help interpret complex documents. These filings trace Sonim’s history as a rugged mobile solutions provider and its transition toward a new business focus on the DNA X decentralized finance trading platform.
Investors can review Form 10-Q and 10-K reports (when available) for detailed discussions of net revenues from phones, wireless internet data devices, accessories, and software, as well as information on operating expenses, liquidity, and risk factors. Quarterly earnings releases are often furnished on Form 8-K, as seen in the October 31, 2025 filing that attaches Sonim’s third quarter 2025 financial results and commentary on product launches and the pending asset sale to NEXA.
Multiple Form 8-K filings document material events central to understanding SONM’s evolution. These include the July 2025 asset purchase agreement with a buyer affiliated with Social Mobile (later referenced as NEXA) to acquire substantially all assets related to Sonim’s enterprise 5G solutions and rugged mobility business; the November 24, 2025 amendment to that agreement; Nasdaq listing notices; and the October 2025 reverse stock split and authorized share increase. A December 18, 2025 Form 8-K details the convertible promissory note with DNA Holdings Venture, Inc. and the membership interest purchase agreement through which Sonim acquired DNA X LLC, a company engaged in the DNAX DeFi on-chain trading protocol.
Registration statements such as the Form S-1 and S-1/A filed in late 2025 describe Sonim’s committed equity facility with Chardan Capital Markets LLC, outlining how the company may sell newly issued common shares over time, the associated risks, and the potential impact on capital structure. The DEF 14A proxy statement for the October 16, 2025 special meeting provides insight into stockholder votes on the reverse stock split, authorized share increase, and related corporate proposals.
On this page, AI-generated summaries can highlight key points from lengthy filings: for example, how a new financing arrangement works, what conditions apply to the NEXA asset sale, or how the DNA X acquisition affects governance and ownership. Users can quickly identify sections related to strategic transactions, listing compliance, equity and debt financing, and the planned rebranding to DNA X, Inc. For those researching insider activity, the platform also surfaces Form 4 insider transaction reports when filed, enabling a consolidated view of executive and director share dealings.
Together, Sonim’s SEC filings and AI explanations offer a structured way to understand the company’s financial position, strategic decisions, and the regulatory steps behind its shift from rugged mobility to a DeFi-oriented crypto trading platform business.
Sonim Technologies, Inc. is soliciting votes at a 2025 special meeting on four proposals: a reverse stock split, an increase in authorized common stock from 100,000,000 to 1,000,000,000, an increase in shares reserved under its equity incentive plan, and an adjournment proposal. The company reports 17,781,919 shares outstanding and a Nasdaq closing price of $0.57. If approved, reserved shares for awards would increase from 43,927 to 1,043,927 (illustrative figures shown). The proxy discloses outstanding warrants of 1,133,625 and certain majority and voting thresholds required to approve each proposal.
This Schedule 13G reports that the Reporting Persons collectively beneficially own 908,410 shares of Sonim Technologies, Inc. common stock, representing 5.1% of the class based on 17,738,905 shares outstanding plus 150,000 shares underlying warrants.
The holdings are held across private funds managed by 1 Main Capital: Fund 1 directly holds 622,380 shares plus warrants for 150,000 shares and Fund 2 holds 136,030 shares, with the Adviser (1 Main Capital Management, LLC), the General Partner and Principal Yaron Naymark identified as reporting persons. The filing states the stake was not acquired to influence control and is signed by Yaron Naymark.
Sonim Technologies reported that it received a Nasdaq notice on August 22, 2025 stating that it no longer meets continued listing standards for the Nasdaq Capital Market. The company’s stockholders’ equity was $1,334,000 as of June 30, 2025, below the required $2.5 million, and it also failed alternative criteria based on market value of listed securities and net income from continuing operations. Sonim has 45 days, until October 6, 2025, to submit a plan to regain compliance, and Nasdaq may grant up to 180 days from the notice date to demonstrate compliance if the plan is accepted. The company is evaluating options but warns there is no assurance its plan will be accepted or that it will regain compliance, and its shares could ultimately be delisted, although it would have the right to appeal any delisting determination.
Sonim Technologies entered a receivables factoring agreement under which eligible receivables will be purchased at a 15% discount, providing up to €3,000,000 of financing. The facility carries an interest rate equal to the greater of 4.00% or EURIBOR+3.50%, a late fee of 0.18% for invoices outstanding more than 95 days, a risk surcharge of 0.06% of a preapproved limit, and a non-utilization fee of €70,000 if annual sales to Tradewind are below €15,000. The term is 12 months with automatic annual extension and either party may terminate with three months' notice.
The company also amended prior subscription agreements to lower the Subscription Warrant exercise price to $0.75. Because stockholders did not approve an increase in shares under the 2019 Equity Incentive Plan, the compensation committee approved a Substitute Cash Grant to non-employee directors that is designed to replicate RSUs valued at $60,000; those phantom RSUs vest on a change in control or at the 2026 annual meeting and the cash award is payable at the vesting event.
Sonim Technologies, Inc. reported consolidated total assets of $36,078 and cash and cash equivalents of $2,006 at June 30, 2025. Total net revenues were $11,190 for the three months and $27,911 for the six months ended June 30, 2025, with gross profit of $845 for the quarter. The company recorded a net loss of $7,475 for the quarter and $7,017 for the six months, and used $14,488 of cash in operating activities during the six months. Stockholders' equity remained in a deficit of $1,334 and accumulated deficit totaled $290,625.
The company entered a material Asset Purchase Agreement dated July 17, 2025 to sell substantially all assets of its enterprise 5G solutions business for $15,000 in cash plus up to $5,000 of earn-out tied to Net Revenue above $70,000 for the 12-month period beginning July 1, 2025. Sonim also completed a July 2, 2025 public offering that raised net proceeds of approximately $4,800 and sold a promissory note for approximately $2,320, and obtained access to additional receivables financing (up to 0,000). Management states it believes these proceeds, together with cash at June 30, 2025, are sufficient to meet obligations for the next twelve months following the filing date.
Sonim Technologies, Inc. filed a current report to note that it has released its latest quarterly financial results. On August 8, 2025, the company issued a press release announcing results for its fiscal quarter ended June 30, 2025. That press release is included as Exhibit 99.1 to this report, allowing investors to review the detailed figures and commentary. The filing is made under the item covering results of operations and financial condition and is primarily an administrative step to formally furnish the earnings release.